Luftal

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Luftal

What is Luftal?

Luftal is a medication primarily used to alleviate symptoms associated with the accumulation of excess gas in the digestive tract. It is frequently utilized to treat abdominal discomfort, bloating, and the sensation of pressure or fullness caused by gas in the stomach or intestines.

Therapeutic Class and Composition

The active ingredient in Luftal is simethicone. Simethicone is classified as an antifoaming agent or an antigas medication. It is not absorbed into the bloodstream; instead, it acts locally within the gastrointestinal tract to alter the surface tension of gas bubbles.

Mechanism of Action

Luftal works through a physical process rather than a metabolic one. In the digestive system, gas can become trapped in small, mucus-covered bubbles, making it difficult for the body to expel. Simethicone acts by decreasing the surface tension of these bubbles, causing them to coalesce into larger bubbles. These larger volumes of gas are then more easily eliminated from the body through natural processes such as burping or passing flatus.

Common Applications

Luftal is commonly used in various clinical and everyday contexts, including:

  • Relief of Flatulence: Reducing the discomfort and frequency of intestinal gas.
  • Abdominal Bloating: Addressing the physical distension and tightness caused by trapped gas.
  • Diagnostic Preparation: In some instances, it is used before medical imaging or endoscopic procedures, such as abdominal ultrasounds or gastroscopies, to clear gas shadows and improve the clarity of the images.
  • Post-Operative Recovery: Assisting patients who experience gas pain following abdominal surgery.

Because it acts physically and is not absorbed by the body, it is often used for symptomatic relief across different age groups, ranging from infants with colic symptoms to adults with functional digestive issues.

Regulatory References

  1. MedlinePlus Drug Information
  2. NIH StatPearls

What side effects are possible with Luftal?

Possible Side Effects and Safety Information: Official Regulatory Overview

The safety profile of Luftal, which contains simethicone, is distinguished by its non-systemic action; the medicine is not absorbed into the bloodstream and acts exclusively within the gastrointestinal tract. Consequently, the incidence of adverse reactions is documented as low in official regulatory documents.


Adverse Reactions and Frequency Classification

Based on safety information documented in official government sources, simethicone's adverse effects are typically associated with skin and gastrointestinal systems. No adverse reactions are officially classified as Common or Very Common.

System-Organ Class Examples of Reported Reactions Official Frequency Classification
Skin and Subcutaneous Tissue Disorders Rash, Pruritus, Urticaria (Hives) Not known
Gastrointestinal Disorders Nausea, Constipation Not known
Immune System Disorders Severe allergic reactions, Angioedema, Facial Edema Not known

Adverse reactions, including severe allergic reactions (hypersensitivity) such as angioedema and facial edema, have been reported in the post-marketing setting. The classification 'Not known' is used by regulatory authorities for effects reported spontaneously after marketing where a reliable incidence rate cannot be established.


Safety-Related Restrictions and Considerations

The official label confirms the use of simethicone is established for managing gas discomfort in pediatric populations. A primary high-level safety constraint listed in official labeling is that the medication should not be used in patients with known or suspected intestinal perforation or intestinal obstruction.

Overdose and Emergency Response

The official regulatory documentation for the active ingredient in Luftal, Simethicone, establishes a distinct profile regarding overexposure due to the drug's inherent physiological properties. Government regulatory authorities classify Simethicone as physiologically and chemically inert, confirming that it is not absorbed systemically into the bloodstream. This absence of systemic activity is the foundational principle for its overdose classification.

Consequently, no specific systemic signs, symptoms, or life-threatening outcomes associated with chemical drug toxicity are expected or documented in official labeling. Prescribing information from national health agencies consistently states that intoxication is virtually ruled out and that serious adverse effects are not anticipated even with overexposure. Management for accidental overexposure is officially described as symptomatic and supportive, and regulatory documents affirm that no specific antidote is known.

However, government regulatory guidance mandates specific emergency actions for any suspected ingestion beyond the intended use. Individuals are required to seek professional assistance or contact a Poison Control Center immediately for any accidental overdose. This is a standard precautionary measure designed to ensure clinical observation and supportive treatment can be provided.

Therapeutic Uses of Luftal

Luftal (Simethicone) is commonly used to provide symptomatic relief from symptoms related to the presence of excess gas in the digestive tract. It is used to treat symptoms of gas such as uncomfortable or painful pressure, fullness, and bloating, managing symptoms that create noticeable functional strain. The medication is generally applied in contexts where additional symptomatic support is needed for various patient groups, including adults, pediatric patients, and individuals managing postoperative gas pain.


Symptom Domains and Therapeutic Benefit

This medication is used for managing symptoms related to physical discomfort caused by trapped gas, targeting the core symptom cluster of abdominal fullness, pressure, and palpable bloating (distention). It is commonly used across conditions presenting with acute or episodic symptom patterns. The goal is to address symptom clusters that may become intense or disruptive and contribute to improved comfort during symptomatic periods.

Luftal is relevant for easing the gas-induced discomfort associated with infant colic and is also applied in clinical scenarios to reduce gas interference before diagnostic imaging, such as ultrasound or colonoscopy. The therapeutic domains often managed include symptoms of flatulence, functional bloating, and gas pain. This action helps support the patient during difficult episodes by easing distress.


Quick Fact: The medication is commonly used to help with symptoms that create noticeable functional strain.

Regulatory References

  1. Simethicone is used to treat the symptoms of gas such as uncomfortable or painful pressure, fullness, and bloating

Eligibility and Restrictions for Use

Luftal (Simethicone) eligibility is broadly established across the population, primarily due to its non-systemic action. However, official regulatory documents define clear constraints and absolute contraindications for use.

Who Must Not Use Luftal (Contraindications)

Use is absolutely contraindicated for individuals with known hypersensitivity or allergy to simethicone or any of the product’s components. The medicine is also generally contraindicated in patients with suspected or confirmed bowel obstruction or gastrointestinal perforation.

Population and Condition Eligibility

Population Group Regulatory Status
Adults, Adolescents, Older Adults Established and permitted.
Infants and Children Established for use, but non-prescription use in infants often requires medical supervision.
Pregnancy and Lactation Acceptable status, as the non-absorbed drug is not expected to pass into the bloodstream or breast milk.
Renal or Hepatic Impairment No specific limitations are documented in standard labeling.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Luftal (Simethicone) is uniquely narrow due to its nature as a non-systemic anti-flatulent agent that is not absorbed into the bloodstream. Consequently, it does not participate in typical pharmacokinetic interactions involving metabolic enzymes (e.g., CYP pathways) or cellular drug transporters.

Documented Physicochemical Interaction

The only class of substances officially documented to interact with Simethicone is oral thyroid hormone replacement therapy. This interaction is physicochemical, stemming from the physical binding of Simethicone to the thyroid drug (such as Levothyroxine) within the gut lumen, which reduces the amount of the thyroid medicine available for absorption.

Interacting Substance Category Interaction Outcome Administration Requirement
Oral Thyroid Hormones Reduced systemic exposure of the hormone Separate administration by at least four hours

Regulatory documents specify that co-administration may lead to a decrease in the systemic exposure and effectiveness of the oral thyroid hormone. To mitigate this effect, official labeling requires a mandatory timing separation rule: Simethicone and oral thyroid hormones must be administered at least four hours apart.

No specific interactions with food, alcohol, supplements, or herbal products are explicitly documented in regulatory labeling for single-ingredient Simethicone.

Mechanism of Action

Luftal, whose active constituent is simethicone, functions exclusively as a non-systemic surfactant within the gastrointestinal lumen. Its biological target is the physical structure of aerated liquid media, specifically the surface tension of small gas bubbles entrapped within the chyme.

Simethicone's molecular mechanism is a physical interaction type where the polydimethylsiloxane component reduces the cohesive forces at the gas-liquid interface. This action causes the destabilization of the foam matrix and the subsequent rupture of individual, small, dispersed gas bubbles. The downstream cascade involves the coalescence of numerous small gas pockets into fewer, larger gas masses. This increase in the size of the luminal gas volume facilitates its mechanical movement. The system-level physiological consequence is the modulation of intra-luminal gas transit, promoting the elimination of the aggregated gas volume via the upper and lower gastrointestinal orifices (eructation or flatus). Simethicone is not absorbed across the enterocyte barrier and is excreted unchanged in the feces, preventing systemic pharmacokinetic or pharmacodynamic interactions.

Dosage and Administration Information

How to Use Luftal: Official Administration Guidelines

Luftal (simethicone) is administered via the oral route only, consistent with its non-systemic action exclusively within the gastrointestinal tract lumen. The usage pattern is defined by specific dose ranges, frequency limits, and preparation requirements as established by regulatory authorities.


Administration Protocol

The medicine is typically used on an as-needed (PRN) basis for acute episodes, with dosing often scheduled after meals and at bedtime. Dosage must not exceed the prescribed limits, which include a standard maximum daily dose of 500 mg for adults engaging in self-medication.

Age Group Standard Dose per Use Maximum Daily Dose (24h)
Adults 40 mg to 125 mg 500 mg (OTC)
Children (2–12 years) 40 mg 480 mg
Infants (under 2 years) 20 mg 240 mg

Dosage Form Preparation

Proper administration requires attention to the specific dosage form. Chewable tablets must be chewed thoroughly before swallowing to facilitate the anti-foaming action. Liquid oral suspensions or drops must be shaken well prior to use and measured accurately using the provided calibrated dropper. The drops may be mixed with 1 ounce (30 mL) of cool water or other liquid. For a missed dose on a structured regimen, the general rule is to skip the missed dose and resume the regular schedule, without taking a double dose.

Use of single, higher doses, such as up to 320 mg, is a documented application for reducing gas interference prior to certain diagnostic procedures.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Luftal (Simethicone)


Evidence for Symptomatic Relief of Gas and Bloating

Research exploring Simethicone was centered on short-term Randomized Controlled Trials (RCTs) and subsequent scientific reviews. These studies were applied in studies examining patient-reported experiences related to physical discomfort, such as abdominal pressure, fullness, and general gas discomfort in adult populations.

The trials monitored patient-reported outcomes describing perceived discomfort over defined time intervals. Some studies reported measurements related to symptom intensity over the short follow-up period. However, research highlights that findings were mixed, with some systematic reviews noting that reported outcomes were not consistently different from placebo in all cases of generalized gas relief. Certainty remains low regarding the research available for long-term use; long-term outcomes following consistent use are not fully established.


Evidence for Use in Pediatric Gas and Infant Colic

Studies monitored Simethicone in research contexts involving fluctuating or unstable symptoms, specifically in infants diagnosed with colic. The research involved RCTs, often comparing Simethicone to a placebo, to measure patient-reported outcomes describing perceived discomfort. Studies monitored the primary outcome of average daily crying duration in infants.

Subsequent and larger systematic reviews have generally found that Simethicone was not consistently associated with a statistically significant difference in daily crying time when compared to placebo. Research describes that findings were mixed across trials, and the outcomes were subject to high variability. Data for certain groups remain insufficient, and follow-up durations were limited, typically spanning only a few weeks.


Evidence for Medical Imaging and Diagnostic Procedures

A distinct and consistent body of research has been conducted on Simethicone for its use as a defoaming agent during clinical procedures like colonoscopy and gastroscopy. These studies were evaluated in populations of adult patients undergoing these diagnostic procedures. Research examined physical outcomes, such as the clarity of the gastrointestinal tract lining.

Findings indicate that the research highlights changes measured during the study period, consistently reporting a pattern where adding Simethicone to the bowel preparation was associated with higher scores for mucosal visualization and improved clearance of small bubbles compared to preparation solutions used alone. Research contributes to the broader evidence landscape by describing observed changes in a temporary physiological imbalance in an acute setting. Results apply only to the populations studied—patients undergoing immediate diagnostic procedures.

Key Studies & References

  1. MedlinePlus Drug Information: Simethicone

Frequently Asked Questions (FAQ)

Common questions about Luftal (FAQ)

Q: Can I take Luftal with painkillers like paracetamol or ibuprofen?

Official drug interaction checkers generally report no known drug-drug interaction between simethicone and single-ingredient acetaminophen or ibuprofen. Because simethicone is not absorbed into the bloodstream, it has a very limited interaction profile. Consulting a healthcare professional is advised before combining medications.

Q: Can Luftal be taken on an empty stomach?

Yes, Luftal can be taken when gas discomfort occurs, regardless of food intake. While it is often recommended to take simethicone after meals and at bedtime for maximum effect against digestive gas, its physical, non-systemic mechanism allows for flexible timing whenever symptoms arise.

Q: Are there any dietary restrictions when using Luftal?

According to official regulatory documents, no specific dietary restrictions are listed. There are no documented interactions with food or alcohol for single-ingredient simethicone. This is because the medicine acts physically in the gut and is not absorbed systemically.

Q: Can Luftal interact with oral contraceptives?

Official drug interaction information does not report a known interaction between simethicone and oral contraceptives. Since simethicone is a non-systemic agent that acts only in the digestive tract and is not absorbed, it is not expected to interfere with the effectiveness of birth control pills.

Q: Is it safe to use Luftal if I have a history of kidney problems?

Simethicone is not absorbed into the bloodstream and is not metabolized by the kidneys. Therefore, official product information indicates that no specific dosage adjustments or limitations are typically recommended in official labeling for individuals with renal impairment.

Q: What should I do if Luftal doesn't seem to be helping my gas?

Official anti-gas product labeling typically advises stopping use and consulting a healthcare provider if gas symptoms worsen, if abdominal swelling or bulging continues, or if symptoms persist. This is to ensure that a more serious underlying condition is not being masked.

Q: Can I take Luftal with other supplements like probiotics?

Because simethicone acts physically in the gut and is not absorbed into the body, it is generally not expected to interact with supplements like probiotics. It is advised to consult with a healthcare professional regarding the combination of any supplement and medication.

Q: Does Luftal work for gas related to irritable bowel syndrome (IBS)?

Simethicone is approved for the symptomatic relief of gas, pressure, and bloating, which are common symptoms that may be associated with Irritable Bowel Syndrome (IBS). However, it only addresses the gas symptoms and is not a treatment for the underlying cause of IBS itself.

Q: What is the consistency and taste of Luftal drops for babies?

Luftal drops are an oral suspension, meaning they are a liquid form. They are often formulated with a specific flavoring to make them more palatable for infants, though the exact taste and consistency may vary slightly by manufacturer.

Q: Can I crush or split the Luftal tablets?

Chewable tablets must be chewed thoroughly before swallowing to activate the medicine. Regular tablets and capsules, if available, should be swallowed whole. They should be used according to the product's specific instructions. Consult a healthcare provider if there is a need to alter the dosage form.

Q: What does the latest research say about the safety profile of Luftal's active ingredient?

Simethicone's safety profile is consistently described as being well-tolerated in official documents due to its non-systemic action. It is generally well-tolerated with a minimal risk of serious systemic side effects, even with new research confirming this established classification.

Q: Are there any known interactions between Luftal and herbal remedies?

Official regulatory documents generally state that no specific interactions with herbal remedies are explicitly documented for single-ingredient simethicone. This is because the medicine acts physically in the gut and is not absorbed into the body.

Q: Is Luftal suitable for vegans or vegetarians?

Suitability for specific diets depends on the inactive ingredients used in the formulation. It is necessary to check the product's inactive ingredients list, as some forms, like softgel capsules, may contain gelatin or other non-vegan components.

Q: Is it normal to feel a bubbling or rumbling sensation after taking Luftal?

Luftal's mechanism of action causes small, trapped gas bubbles to merge into larger ones to facilitate their passage. This physical change in the gut can potentially be perceived by the user as a temporary bubbling or rumbling sensation as the gas starts to move.

Q: Does Luftal help with burping or only flatulence?

Simethicone works to promote the elimination of gas through both the upper and lower gastrointestinal orifices. Therefore, the medicine is intended to help with both belching (burping) and flatus (passing gas).

Q: Can I use Luftal if I have a condition like Crohn's disease or ulcerative colitis?

While the absolute contraindications relate to bowel obstruction or perforation, official labeling does not prohibit its use for gas relief in patients with conditions like Crohn’s disease or ulcerative colitis. A healthcare provider should be consulted to determine if it is appropriate for gas relief given your specific health status.

Q: Can people with lactose intolerance use Luftal?

The inclusion of lactose is determined by the inactive ingredients used in a specific formulation. Many simethicone products are marketed as lactose-free, but it is recommended to verify the specific ingredient list on the product packaging.

Q: What are the signs that Luftal is starting to work?

The product is designed to relieve symptoms of gas. Signs that the medicine is working include a noticeable reduction in the feelings of pressure, bloating, and fullness caused by trapped gas.

Q: How quickly does Luftal usually start working for gas relief?

Due to its physical, non-systemic action, simethicone starts working quickly to break up gas bubbles in the stomach and intestines. Symptomatic relief is often reported to begin within a few minutes of taking the dose.

Q: How long does the effect of Luftal last?

The duration of relief varies by individual. The medicine is dosed on an as-needed basis, typically after meals and at bedtime, up to four times daily. This frequency suggests that the symptomatic relief from a single dose typically lasts for several hours.

Q: Can I take Luftal every day for chronic gas issues?

Simethicone is indicated for the temporary relief of gas. If gas issues are chronic and daily, product labeling suggests consulting a healthcare provider before continuous daily use to ensure any underlying condition is addressed.

Q: Is there a maximum number of days in a row I should take Luftal?

Official labeling for anti-gas products typically advises users to stop taking the medicine and consult a doctor if symptoms persist for more than seven days. This is a common precaution for over-the-counter medication.

Q: What happens if I accidentally take more Luftal than recommended?

In the event an overdose is suspected, official labeling advises immediately seeking medical attention or contacting a Poison Control Center.

Q: Are there any long-term side effects associated with regular Luftal use?

Due to its non-systemic action (it is not absorbed into the body), simethicone carries a minimal risk of serious systemic side effects. However, long-term safety data is not fully established, and use beyond temporary relief is typically advised to be medically reviewed.

Q: Does Luftal affect the digestive process or nutrient absorption?

Simethicone's action is purely physical, focusing only on breaking down gas bubbles. It is not reported to interfere with the chemical digestive process or the general absorption of nutrients in the gut.

Q: Can Luftal cause constipation or diarrhea?

Official adverse reaction reports list gastrointestinal disturbances, including constipation and nausea, as possible effects. While the frequency of these side effects is not known, they have been reported.

How should Luftal be stored and disposed of?

How to Store and Dispose of Luftal

Official storage and disposal requirements for Luftal (simethicone) maintain product stability and ensure safety, as directed by regulatory labeling.


Storage Conditions

The medicine must be stored at room temperature, typically between 20 C and 25 C. It must be kept from freezing and stored away from excess heat and moisture. The product should remain in its original container, which must be kept tightly closed to protect its integrity. For safety, the medication must be stored out of the reach and sight of children.


Disposal Instructions

Unused or expired simethicone must not be thrown away in household wastewater or down the toilet. Disposal should follow local pharmaceutical waste regulations, such as utilizing a medicine take-back program, to prevent environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Luftal found in:

A-Z Index: